A Pilot Study, to Evaluate the Safety and Efficacy of Topically Applied Onabotulinum Toxin A Delivered through a Novel Iontophoresis Device in Subjects with Axillary Hyperhidrosis
Main Article Content
Keywords
hyperhidrosis, pilot study, safety, efficacy, topical, onabotulinum toxin A, iontophoresis
References
1. Doolittle, J., Walker, P., Mills, T. & Thurston, J. Hyperhidrosis: an update on prevalence and severity in the United States. Arch. Dermatol.
Res. 308, 743–749 (2016)
2. McLenon, J. & Rogers, M. A. M. The fear of needles: A systematic review and meta-analysis. J. Adv. Nurs. 75, 30–42 (2019)
3. Naumann, M. & Lowe, N. J. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group,
double blind, placebo controlled trial. BMJ 323, 596 (2001).
Res. 308, 743–749 (2016)
2. McLenon, J. & Rogers, M. A. M. The fear of needles: A systematic review and meta-analysis. J. Adv. Nurs. 75, 30–42 (2019)
3. Naumann, M. & Lowe, N. J. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group,
double blind, placebo controlled trial. BMJ 323, 596 (2001).